NCT06496022

Brief Summary

Assessing frailty syndrome in elderly patients in Almaty To study the features of the clinical course in the group of patients with a pre-frailty and in the group with frailty syndrome

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
600

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Mar 2024

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2024

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

July 3, 2024

Completed
8 days until next milestone

First Posted

Study publicly available on registry

July 11, 2024

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2024

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2025

Completed
Last Updated

July 15, 2024

Status Verified

July 1, 2024

Enrollment Period

10 months

First QC Date

July 3, 2024

Last Update Submit

July 12, 2024

Conditions

Keywords

frailtyelderlyrisk factorsprediction

Outcome Measures

Primary Outcomes (1)

  • frailty prevalence

    A FRAIL scale or Fried frailty criteria is used (weight loss, exhaustion, low physical activity, slowness, weakness). The participants were divided into three stages: non-frail (score 0), pre-frail (score 1-2) and frail (score 3-5).

    1 March 2024 - 31 December 2024

Study Arms (1)

cohort

Patients will be divided into 2 groups: pre-frailty and frailty using Frail Scale.

Diagnostic Test: Frail scaleDiagnostic Test: Barthel scaleDiagnostic Test: SARC-FDiagnostic Test: FRAXDiagnostic Test: Mini-Cog scaleDiagnostic Test: dynamometry

Interventions

Frail scaleDIAGNOSTIC_TEST

FRAIL scale for determining frailty (tired most of the time in the last 4 weeks; the presence of more than 5 diseases; difficulty or inability when climbing stairs and walking around the block; weight loss of more than 5% of the previous weight in the last 6 months).

cohort
Barthel scaleDIAGNOSTIC_TEST

The Barthel scale is used to determine the degree of independence in daily life, the patient's household activity, the assessment of the quality of life and the necessary care.

cohort
SARC-FDIAGNOSTIC_TEST

The SARC-F scale is used to identify muscle dysfunction (difficulty lifting things over 4.5 kg, walking around the room, difficulty climbing from a chair and up 10 steps, whether the respondent has fallen in the last year).

cohort
FRAXDIAGNOSTIC_TEST

FRAX Scale (Kazakhstan platform) fracture and osteoporosis risk assessment on the website https://frax.shef.ac.uk/FRAX/tool.aspx?country=72

cohort
Mini-Cog scaleDIAGNOSTIC_TEST

The Mini-Cog scale defines cognitive impairment (cognitive impairment - when scoring less than 3 points based on remembering three words and evaluating the task of drawing a clock).

cohort
dynamometryDIAGNOSTIC_TEST

carpal dynamometry (sarcopenia is exhibited at values below 26 units for men and below 16 units for women).

cohort

Eligibility Criteria

Age60 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

patients from polyclinics of nursing homes in Kazakhstan

You may qualify if:

  • Patients over 60 years of age
  • Signatories of the informed consent to participate in the study

You may not qualify if:

  • Not agreeing to participate in scientific research
  • Elderly people who do not understand the purpose of the study
  • Severe and decompensated diseases that do not allow the study.
  • Concomitant oncological diseases
  • Concomitant neurological and mental disorders that impede the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kazakh National Medical University

Almaty, Tole Bi 94, 050012, Kazakhstan

Location

MeSH Terms

Conditions

Frailty

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and Symptoms

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator, Assistant of the department of General Medical Practice

Study Record Dates

First Submitted

July 3, 2024

First Posted

July 11, 2024

Study Start

March 1, 2024

Primary Completion

December 31, 2024

Study Completion

March 1, 2025

Last Updated

July 15, 2024

Record last verified: 2024-07

Data Sharing

IPD Sharing
Will not share

patients data is available upon request from the authors with no identifiable information

Locations